ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $6,316,000 | -74.7% | 515,583 | -79.4% | 0.32% | -75.4% |
| Q3 2014 | $24,997,000 | -55.3% | 2,504,677 | -66.1% | 1.29% | -57.5% |
| Q2 2014 | $55,941,000 | +57.2% | 7,389,810 | -31.7% | 3.03% | +48.6% |
| Q1 2014 | $35,588,000 | -0.9% | 10,816,953 | 0.0% | 2.04% | -3.2% |
| Q4 2013 | $35,901,000 | +1.5% | 10,816,953 | -7.6% | 2.10% | -12.6% |
| Q3 2013 | $35,373,000 | -59.3% | 11,712,953 | +6.8% | 2.41% | -58.8% |
| Q2 2013 | $86,889,000 | – | 10,967,853 | – | 5.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |